Low glycemic load after digestion of native starch from the indigenous tuber Belitung Taro (Xanthosomo sogittifolium) in a dynamic in vitro model of the upper GI tract (TIM-1)

Background: Low glycemic foods are beneficial for people with type II diabetes. At the same time, sustained glucose release is also beneficial for people suffering from glycogen storage diseases. Taro (Xanthosoma sagittifolium)is a tuber indigenous to Indonesia, which has starch as the major storage...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Food & nutrition research 2020-07, Vol.64, p.1-5, Article 4623
Hauptverfasser: Surono, Ingrid S., Verhoeven, Jessica, Venema, Koen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: Low glycemic foods are beneficial for people with type II diabetes. At the same time, sustained glucose release is also beneficial for people suffering from glycogen storage diseases. Taro (Xanthosoma sagittifolium)is a tuber indigenous to Indonesia, which has starch as the major storage carbohydrate. Objective: The aim of the current study was to determine the speed of digestion of native and modified taro starch, compared to free glucose and wheat starch. Design: This was investigated in a validated, dynamic computer-controlled in vitro model of the stomach and small intestine (TIM-1). Samples were taken from the dialysate, which reflected glucose absorbed in the blood stream. Results: Native taro starch showed a similar to 1.5-fold reduced digestibility compared to glucose and a similar to 1.35-fold compared to wheat starch. In addition, digestion of native taro starch was moved towards the ileum, and later in time compared to glucose and wheat. With modified taro starch, these effects were not observed. Conclusion: In conclusion, native taro starch showed a lower glycemic load than wheat starch and modified taro starch and could be used as a substitute for refined foods by diabetics and people suffering from other glucose metabolic diseases.
ISSN:1654-6628
1654-661X
1654-661X
DOI:10.29219/fnr.v64.4623